Search results for “STK11” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 31 patents, we discovered top 17 key players by total patent application. Bristol Myers Squibb Co., BerGenBio ASA, The Board of Regents of The University of Texas System are dominant in this area. They take 48.39% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 9
BerGenBio ASA
Hordaland, Norway
Patent: 3
The Board of Regents of The University of Texas System
Texas, United States
Patent: 3
Genaissance Pharmaceuticals, Inc.
Connecticut, United States
Patent: 3
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 2
NanJing Adicon Clinical Laboratories,Co.,Ltd
Jiangsu Sheng, China
Patent: 2
MedImmune LLC
Louisiana, United States
Patent: 1
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 1
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 1
Jiangsu Weizhen Biomedical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents applied in the last 5 years. We discover 16 most active companies in this area. The fast-growing The Board of Regents of The University of Texas System, Bristol Myers Squibb Co., BerGenBio ASA take 58.33% of patent filing during this period.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 8
Bristol Myers Squibb Co.
New York, United States
Patent: 3
BerGenBio ASA
Hordaland, Norway
Patent: 3
NanJing Adicon Clinical Laboratories,Co.,Ltd
Jiangsu Sheng, China
Patent: 2
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 2
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 1
MedImmune LLC
Louisiana, United States
Patent: 1
Sorbonne Université
France
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
New York University
New York, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents in last 5 years, we discover 15 new entrants. The Board of Regents of The University of Texas System, BerGenBio ASA, NanJing Adicon Clinical Laboratories,Co.,Ltd are the most active new entrants in this area.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 8
BerGenBio ASA
Hordaland, Norway
Patent: 3
NanJing Adicon Clinical Laboratories,Co.,Ltd
Jiangsu Sheng, China
Patent: 2
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 2
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 1
MedImmune LLC
Louisiana, United States
Patent: 1
Sorbonne Université
France
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
New York University
New York, United States
Patent: 1
Wuhan Chenxi Life Science Co., Ltd.
Hubei Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 21 patents, we discovered top 6 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, New York University, Zhejiang University are dominant in this area. They take 61.90% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 2
New York University
New York, United States
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
Université de Paris 5 René Descartes
France
Patent: 1
Université Paris Diderot-Paris 7
France
Patent: 1
Sorbonne Université
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: